no GLP-1 receptor agonist use (n = 55,033)
A 2006 Achilles-detachment study by Krivic and colleagues in the same journal applied BPC-157 intraperitoneally once daily at 10 g/kg, 10 ng/kg, or 10 pg/kg for 30 days in rats and reported that tendon-to-bone tissue, which did not heal spontaneously in saline controls, recovered with BPC-157 treatment, with directionally improved load-to-failure, stiffness, Young's modulus, and collagen organization at days 121, including in animals where healing had been impaired by 1 mg/kg 6-methylprednisolone though the abstract does not report numeric effect sizes or p-values
GLP-1 also slows down how quickly your stomach empties, which helps you feel full longer and can reduce how much you eat
BPC-157 (Body Protection Compound-157) is a 15-amino acid peptide derived from a protein found in gastric juice
Dedicated constitutional (germline) testing using a DNA and RNA-based platform (Invitae Multi-Cancer+RNA Panel) was performed on whole blood and was negative for all alterations, including in PRKAR1A
IV use could also be needed when there are gastrointestinal complications leading to the need for the liquid to bypass the stomach